Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DAPAGLIFLOZIN Cause Atrioventricular block complete? 20 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Atrioventricular block complete have been filed in association with DAPAGLIFLOZIN (QTERN). This represents 0.1% of all adverse event reports for DAPAGLIFLOZIN.

20
Reports of Atrioventricular block complete with DAPAGLIFLOZIN
0.1%
of all DAPAGLIFLOZIN reports
10
Deaths
16
Hospitalizations

How Dangerous Is Atrioventricular block complete From DAPAGLIFLOZIN?

Of the 20 reports, 10 (50.0%) resulted in death, 16 (80.0%) required hospitalization, and 3 (15.0%) were considered life-threatening.

Is Atrioventricular block complete Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DAPAGLIFLOZIN. However, 20 reports have been filed with the FAERS database.

What Other Side Effects Does DAPAGLIFLOZIN Cause?

Death (2,775) Diabetic ketoacidosis (1,773) Acute kidney injury (982) Off label use (891) Nausea (884) Dehydration (860) Vomiting (838) Dizziness (817) Ketoacidosis (803) Fatigue (785)

What Other Drugs Cause Atrioventricular block complete?

BISOPROLOL (261) VERAPAMIL (210) METOPROLOL (209) AMLODIPINE (149) DILTIAZEM (141) RITUXIMAB (139) AMIODARONE (138) LACOSAMIDE (130) ATORVASTATIN (127) PEMBROLIZUMAB (122)

Which DAPAGLIFLOZIN Alternatives Have Lower Atrioventricular block complete Risk?

DAPAGLIFLOZIN vs DAPAGLIFLOZIN PROPANEDIOL DAPAGLIFLOZIN vs DAPAGLIFLOZIN PROPANEDIOL\METFORMIN DAPAGLIFLOZIN vs DAPRODUSTAT DAPAGLIFLOZIN vs DAPSONE DAPAGLIFLOZIN vs DAPTOMYCIN

Related Pages

DAPAGLIFLOZIN Full Profile All Atrioventricular block complete Reports All Drugs Causing Atrioventricular block complete DAPAGLIFLOZIN Demographics